Stereoselectivity in clinical pharmacokinetics and drug development

European Journal of Drug Metabolism and Pharmacokinetics
D B Campbell

Abstract

No abstract listed.

References

Mar 1, 1976·The Journal of Pharmacy and Pharmacology·D S Hewick, A M Shepherd
May 1, 1978·Clinical Pharmacology and Therapeutics·S H WanD L Azarnoff
Feb 1, 1978·Clinical Pharmacology and Therapeutics·L B WingardG Levy
Feb 1, 1978·Chemical & Pharmaceutical Bulletin·J Watanabe, A Kozaki
Jul 1, 1978·British Journal of Clinical Pharmacology·C Aps, F Reynolds
Feb 1, 1977·Clinical Pharmacology and Therapeutics·G D OlsenN Gerber
Apr 1, 1977·Journal of Pharmacokinetics and Biopharmaceutics·A Yacobi, G Levy
Sep 1, 1976·Clinical Pharmacology and Therapeutics·E JähnchenA Martini
Jan 1, 1990·Acta Pharmaceutica Nordica·G T Tucker
Sep 1, 1989·Journal of Pharmaceutical Sciences·F JamaliF M Pasutto
Sep 1, 1989·Trends in Pharmacological Sciences·M SimonyiB Testa
Apr 1, 1989·Clinical Pharmacology and Therapeutics·R A BoydK M Giacomini
Jan 1, 1989·British Journal of Clinical Pharmacology·L BorgströmJ Paulson
Apr 1, 1989·British Journal of Clinical Pharmacology·P ColangeloP McNamara
Jan 1, 1989·European Journal of Clinical Pharmacology·A M EvansA A Somogyi
May 1, 1989·British Journal of Clinical Pharmacology·M SzutuW Dollman
Aug 1, 1987·The Journal of Pharmacy and Pharmacology·H H Thijssen, L G Baars
Jan 1, 1988·Biochemical Pharmacology·T WalleT E Gaffney
May 1, 1988·The Journal of Pharmacy and Pharmacology·I TamaiA Tsuji
Aug 1, 1988·Journal of Pharmaceutical Sciences·F JamaliA S Russell
Dec 1, 1988·British Journal of Clinical Pharmacology·A M EvansA A Somogyi
Feb 19, 1988·Pharmaceutisch Weekblad. Scientific Edition·K G Feitsma, B F Drenth
Jan 1, 1988·European Journal of Drug Metabolism and Pharmacokinetics·F Jamali
Jan 1, 1988·Journal of Pharmaceutical Sciences·R T FosterS R Alballa
Jan 15, 1988·Biomedical & Environmental Mass Spectrometry·C O MeeseM Eichelbaum
Apr 1, 1988·Clinical Pharmacology and Therapeutics·M H ChandlerR A Blouin
Jan 1, 1988·Josanpu zasshi = The Japanese journal for midwife·T Yamada
May 1, 1988·British Journal of Clinical Pharmacology·T S GillM Rowland
Jul 1, 1987·Clinical Pharmacology and Therapeutics·S ToonM Rowland
Mar 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·B Testa
Jun 1, 1987·Journal of Pharmacokinetics and Biopharmaceutics·J SchüttlerL B Sheiner
May 1, 1986·British Journal of Clinical Pharmacology·O Grech-BelangerM Gilbert

❮ Previous
Next ❯

Citations

Oct 1, 1992·Journal of Clinical Pharmacology·F M Pasutto
Oct 1, 1992·Journal of Clinical Pharmacology·S G NerurkarR L Williams
Jul 1, 1995·European Journal of Drug Metabolism and Pharmacokinetics·V JakovljevićB Banić
Jan 1, 1995·European Journal of Drug Metabolism and Pharmacokinetics·G Pifferi, E Perucca
Nov 25, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Csilla Misl'anová, Milan Hutta
Jan 25, 2003·Journal of Biochemical and Biophysical Methods·Katharina M Rentsch
Jan 25, 2003·Journal of Biochemical and Biophysical Methods·Antonio Marzo, Erich Heftmann
Mar 6, 2003·The Veterinary Journal·P LeesC Waters
Jan 29, 2000·Journal of Veterinary Pharmacology and Therapeutics·M F LandoniP Lees
Jun 1, 1991·British Journal of Clinical Pharmacology·M S Lennard
Jun 1, 1991·Journal of Veterinary Pharmacology and Therapeutics·P DelatourD Fau
Jul 1, 1998·Fundamental & Clinical Pharmacology·F LagrangeM C Saux
Apr 1, 1993·The Journal of Pharmacy and Pharmacology·A J Romero, C T Rhodes
Jan 1, 1993·European Journal of Drug Metabolism and Pharmacokinetics·A Van PeerJ Heykants
Oct 22, 2010·Research in Veterinary Science·E NeirinckxC Vervaet
Jan 1, 1991·Scandinavian Journal of Rheumatology. Supplement·E M Veys
Jan 1, 1994·Journal of Pharmaceutical Sciences·A C CalpenaJ Domenech
Jul 29, 2010·Journal of Pharmaceutical and Biomedical Analysis·Yanqiao Xiang, Gregory W Sluggett
Dec 17, 2004·Journal of Veterinary Pharmacology and Therapeutics·P LeesP L Toutain
Apr 2, 2003·Journal of Veterinary Pharmacology and Therapeutics·A K ArifahP Lees
Mar 21, 2012·Journal of Veterinary Pharmacology and Therapeutics·P LeesP L Toutain
Apr 1, 1994·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·E KashiyamaT Shimizu
Jun 1, 1995·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D McKillopD C Jones
Feb 1, 1991·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P DelatourA Boukraa
Aug 4, 2009·Electrophoresis·Babak JamaliSteen Honoré Hansen
Jan 1, 1992·Chirality·A MarzoE Arrigoni Martelli
Mar 3, 1995·Journal of Chromatography. a·Y Tokuma, H Noguchi
Jul 2, 1998·Journal of Pharmaceutical Sciences·K K MidhaJ W Hubbard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.